Effect of Positive End Expiratory Pressure on intracranial pressure in the neurosurgical patients with the supratentorial tumor

Evaluation and comparison of intracranial pressure in the patients with supra tentorial tumor According to different the positive end expiatory pressure applied during tumor surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017041912782N14

Enrollment

Registered

2017-05-15

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

supratentorial. Benign neoplasm: Brain, supratentorial

Interventions

Intervention 1: The intervention group 1: patients who have 0 cmH2O Positive End Expiratory Pressure. Intervention 2: The intervention group 2: patients who have 5 cmH2O Positive End Expiratory Press

Treatment - Devices

The intervention group 1: patients who have 0 cmH2O Positive End Expiratory Pressure

The intervention group 2: patients who have 5 cmH2O Positive End Expiratory Pressure

The intervention group 3: patients who have 10 cmH2O Positive End Expiratory Pressure

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: neurosurgical patients with supratentorial tumor; Ages 18 to 60 years; Without having hypertension or diabetes; No history of stroke or heart failure. Exclusion criteria: patients with lung diseases such as asthma and chronic obstructive pulmonary disease; Brain shifts to the more than 5 mm from the mid line; Severe hydrocephalus; Loss of consciousness; Closed brain solcus, severe headache; Nausea and vomiting.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intracranial pressure. Timepoint: Before and after the intervention. Method of measurement: Touching the dura mater.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Vahid Salimi

Isfahan University of Medical Sciences

vahid.salimi79@yahoo.com+98 316680048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026